{
    "article_link": "https://doi.org/10.1038/s41467-023-42565-z",
    "data": [
        {
            "id": "data_1",
            "omics": "Epigenomics (ATAC-seq)",
            "link": "https://ngdc.cncb.ac.cn/gsa-human/",
            "format": "BAM (raw reads), BED (processed ACRs)",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA002815"
        },
        {
            "id": "data_2",
            "omics": "Transcriptomics (RNA-seq)",
            "link": "https://ngdc.cncb.ac.cn/gsa-human/",
            "format": "BAM",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA000119"
        },
        {
            "id": "data_3",
            "omics": "Genomics (Whole Genome Sequencing)",
            "link": "https://ngdc.cncb.ac.cn/gsa-human/",
            "format": "BAM (raw reads), processed genomic aberrations",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA005668"
        },
        {
            "id": "data_4",
            "omics": "Epigenomics (ATAC-seq of B-cell progenitors)",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122989",
            "format": "BAM",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE122989"
        },
        {
            "id": "data_5",
            "omics": "Epigenomics (ChIP-seq for H3K27ac)",
            "link": "https://ega-archive.org/",
            "format": "BAM",
            "source": "Blueprint Epigenomic Consortium",
            "public_id": "EGAD00001002421"
        },
        {
            "id": "data_6",
            "omics": "Transcriptomics (DepMap)",
            "link": "https://depmap.org/portal/download",
            "format": "drug-gene pairs (txt/csv)",
            "source": "DepMap",
            "public_id": "DepMap Public 21Q1"
        },
        {
            "id": "data_7",
            "omics": "Drug Response (CTD^2)",
            "link": "https://depmap.org/portal/download",
            "format": "AUC (Processed Data)",
            "source": "Cancer Therapeutics Response Database (CTD^2)",
            "public_id": "Drug Sensitivity AUC (CTD^2)"
        },
        {
            "id": "data_8",
            "omics": "Genomics/Transcriptomics (TARGET)",
            "link": "https://gdc.cancer.gov/about-data/publications#/?groups=TARGET-ALL-P2&years=&order=desc",
            "format": "Processed Data",
            "source": "TARGET",
            "public_id": "phs000464"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Chromatin Accessibility Landscape",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_2",
            "analysis_name": "Comparison with B-cell Progenitors",
            "analysis_data": [
                "data_1",
                "data_4"
            ],
            "label": null
        },
        {
            "id": "analysis_3",
            "analysis_name": "Subtype-specific Chromatin Accessibility",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": null
        },
        {
            "id": "analysis_4",
            "analysis_name": "Allele-specific Open Chromatin (ASOC) Analysis",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": null
        },
        {
            "id": "analysis_5",
            "analysis_name": "Differential Chromatin Accessibility Between Diagnosis and Relapse",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "condition": [
                    "Diagnosis",
                    "Relapse"
                ],
                "subtypes": [
                    "BCR::ABL1",
                    "BCR::ABL1-like",
                    "ETV6::RUNX1",
                    "Hyperdiploidy"
                ]
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "Relapse-free Survival (RFS) Analysis",
            "analysis_data": [
                "data_1",
                "data_8"
            ],
            "label": {
                "group": [
                    "Group A",
                    "Group B"
                ]
            }
        },
        {
            "id": "analysis_7",
            "analysis_name": "ACR-to-Gene Association",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": null
        },
        {
            "id": "analysis_8",
            "analysis_name": "Drug Response Gene Enrichment",
            "analysis_data": [
                "data_6",
                "data_7"
            ],
            "label": {
                "drug": [
                    "Imatinib",
                    "Dasatinib",
                    "Etoposide",
                    "Dexamethasone",
                    "Doxorubicin",
                    "Cyclophosphamide",
                    "Cytarabine",
                    "Methotrexate"
                ],
                "subtypes": [
                    "BCR::ABL1-like",
                    "ETV6::RUNX1"
                ]
            }
        },
        {
            "id": "analysis_9",
            "analysis_name": "Transcription Factor Motif Analysis",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": null
        },
        {
            "id": "analysis_10",
            "analysis_name": "Survival Analysis",
            "analysis_data": [
                "data_1",
                "data_8"
            ],
            "label": {
                "protocol": [
                    "ALL-SCMC-2009",
                    "ALL-SCMC-2015"
                ]
            }
        },
        {
            "id": "analysis_11",
            "analysis_name": "Unsupervised Clustering of Transcription Factors",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "cluster_group": [
                    "Cluster 1",
                    "Cluster 2",
                    "Cluster 3"
                ]
            }
        },
        {
            "id": "analysis_12",
            "analysis_name": "Unsupervised Clustering of B-ALL Samples",
            "analysis_data": [
                "data_1"
            ],
            "label": null
        },
        {
            "id": "analysis_13",
            "analysis_name": "Diagnosis-Relapse Chromatin Accessibility Comparison",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "condition": [
                    "Diagnosis",
                    "Relapse"
                ]
            }
        },
        {
            "id": "analysis_14",
            "analysis_name": "Hyperdiploidy Subgroup Validation in TARGET Cohort",
            "analysis_data": [
                "data_1",
                "data_8"
            ],
            "label": null
        },
        {
            "id": "analysis_15",
            "analysis_name": "Functional Validation of Quies ACRs with H3K27ac",
            "analysis_data": [
                "data_1",
                "data_5"
            ],
            "label": null
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": "Number of ACRs",
            "value": "138,366 (median), ranging from 57,941 to 204,563",
            "features": []
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Overlap with B-cell Progenitor ACRs",
            "value": "98.57% (pre-pro B cells), 98.35% (pro B cells)",
            "features": [
                "IL7R",
                "TCL1A",
                "TCF3",
                "RHOA",
                "ELL",
                "MYC"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "Subtype-specific ACRs",
            "value": "17,981 subtype-specific ACRs identified",
            "features": [
                "E2F6 (ETV6::RUNX1-specific)",
                "RUNX1",
                "ZFP82",
                "SPI1",
                "KLF9",
                "NRF1",
                "RARG",
                "SALL4",
                "CTCF"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "Percentage of ASOC regions",
            "value": "14.39% (median), significantly less than BiOC regions (85.61%)",
            "features": [
                "ARID5B",
                "MECOM",
                "HOXA9"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "Number of differential ACRs per subtype",
            "value": "ETV6::RUNX1: 3604 relapse-high, 610 relapse-low; Hyperdiploidy: 204 relapse-high, 93 relapse-low; BCR::ABL1-like: 278 relapse-high, 468 relapse-low; KMT2A: 61 relapse-high, 1 relapse-low",
            "features": [
                "IL7R",
                "TCL1A",
                "TCF3",
                "RHOA",
                "ELL",
                "MYC"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "Number of RFS-related ACRs",
            "value": "70,573 ACRs (11.29% of 625,287 recurrent c-ACRs)",
            "features": [
                "603 potential target genes",
                "Stem cell/myeloid progenitor-like signatures"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "Number of ACR-gene correlations",
            "value": "116,307 ACR-gene correlations identified (|log2FC| > 1, FDR < 0.05)",
            "features": [
                "1259 potential target genes",
                "Actin cytoskeleton organization",
                "Cell adhesion/migration-related processes",
                "Drug response genes (Imatinib, Dasatinib, etc.)"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "Enrichment in drug response genes",
            "value": "Imatinib (p = 0.0047), Dasatinib (p = 0.0178), Dexamethasone (p = 0.0184), Doxorubicin (p = 0.0167)",
            "features": [
                "Cell adhesion/migration-related genes",
                "Drug response genes (Imatinib, Dasatinib, etc.)"
            ]
        },
        {
            "analysis_id": "analysis_9",
            "metrics": "Number of TFs associated",
            "value": "109 TFs associated with subtype-specific ACRs",
            "features": [
                "E2F6 (ETV6::RUNX1-specific)",
                "RUNX1",
                "ZFP82",
                "SPI1",
                "KLF9",
                "NRF1",
                "RARG",
                "SALL4",
                "CTCF"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "Event-free survival (EFS) and Overall survival (OS)",
            "value": "EFS p = 0.0012, OS p = 0.0002; median survival time and 95% confidence intervals reported",
            "features": [
                "603 potential target genes",
                "Stem cell/myeloid progenitor-like signatures",
                "Cluster 3 (worst prognosis)"
            ]
        },
        {
            "analysis_id": "analysis_11",
            "metrics": "Transcription factor clustering",
            "value": "109 TFs grouped into 9 clusters based on enrichment patterns",
            "features": [
                "E2F6 (ETV6::RUNX1-specific)",
                "RUNX1",
                "ZFP82",
                "SPI1",
                "KLF9",
                "NRF1",
                "RARG",
                "SALL4",
                "CTCF"
            ]
        },
        {
            "analysis_id": "analysis_12",
            "metrics": "Inter-sample correlation of chromatin accessibility",
            "value": "Median correlation coefficient of 0.9604 (Pearson, range 0.8850 to 0.9748)",
            "features": []
        },
        {
            "analysis_id": "analysis_13",
            "metrics": "Shared ACRs between diagnosis and relapse",
            "value": "1.54% (91 out of 5911) of relapse-high ACRs and 0.14% (2 out of 1423) of relapse-low ACRs are shared between subtypes",
            "features": [
                "Shared ACRs in distal enhancer regions (e.g., BENC cluster)"
            ]
        },
        {
            "analysis_id": "analysis_14",
            "metrics": "Differential ACRs between hyperdiploidy subgroups",
            "value": "3156 differential ACRs identified (|log2FC| > 1, FDR < 0.05)",
            "features": [
                "603 potential target genes",
                "Stem cell/myeloid progenitor-like signatures",
                "Lineage plasticity",
                "Drug resistance"
            ]
        },
        {
            "analysis_id": "analysis_15",
            "metrics": "Quies ACRs in gene regions",
            "value": "64.83% of Quies ACRs located in gene regions (Â±5% gene length)",
            "features": [
                "70.59% of Quies ACRs in gene regions show H3K27ac signals",
                "Increased gene transcription in Quies ACRs"
            ]
        }
    ]
}